This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

OncoMed Pharmaceuticals Inc (OMED)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 208.93M 16.26M 11.78M
Receivables 23.00K 4.02M 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 318.74M 71.38M 101.00M
Property, Plant & Equipment, Gross 19.67M 19.12M 18.40M
Accumulated Depreciation & Depletion 15.03M 13.65M 12.25M
Property, Plant & Equipment, Net 4.64M 5.46M 6.15M
Intangibles 0.00 0.00 0.00
Other Non-Current Assets 10.30M 2.92M 55.00K
Total Non-Current Assets 14.94M 8.38M 6.21M
Liabilities & Shareholder Equity
Total Assets 333.68M 79.77M 107.20M
Accounts Payable 5.71M 849.00K 3.41M
Short Term Debt 0.00 0.00 0.00
Other Current Liabilities 11.39M 756.00K 746.00K
Total Current Liabilities 62.02M 20.13M 18.90M
Long Term Debt 0.00 0.00 0.00
Deferred Income Taxes 3.15M 3.75M 4.23M
Other Non-Current Liabilities 150.40M 17.34M 24.24M
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 153.55M 203.87M 211.24M
Total Liabilities 215.56M 224.00M 230.14M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 118.12M -144.23M -122.93M
Common Par 29.00K 1.00K 6.00K
Additional Paid In Capital 292.50M 4.11M 3.13M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -174.43M -148.36M -126.12M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments 14.00K 15.00K 49.00K
Total Capitalization 118.12M -144.23M -122.93M
Total Equity 118.12M -144.23M -122.93M
Total Liabilities & Stock Equity 333.68M 79.77M 107.20M
Total Common Shares Outstanding 29.40M 1.11M 1.11M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 13.53M 22.22M 0.00
Diluted Weighted Shares Outstanding 13.53M 22.22M 0.00
Number of Employees 91 NA NA
Number of Part-Time Employees 0 NA NA
OMED News

OMED OncoMed Pharmaceuticals Inc

Analysts Ratings for OMED

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET OMED ANALYST REPORT

Brokerage Partners

OMED Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs